UNH vs DGX
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Quest Diagnostics Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | DGX |
|---|---|---|
| Price | $418.09 | $241.89 |
| Market cap | $375.28B | $26.70B |
| P/E ratio | 26.9 | 24.1 |
| ROE | 15.77% | 15.32% |
| Profit margin | 3.53% | 9.54% |
| Revenue growth | -0.40% | 10.00% |
| Dividend yield | 2.22% | 1.42% |
| Beta | 0.61 | — |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs DGX in plain English
- UNH is the bigger company — about 14.1× the market cap of DGX.
- DGX is cheaper on earnings (P/E 24.1 vs 26.9).
- UNH earns a higher return on equity (16% vs 15%).
- DGX is growing revenue faster (10% vs -0%).
- UNH has the higher dividend yield (2.22% vs 1.42%).
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
DGX return calculator
See what $1,000 in Quest Diagnostics Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.